Cargando…

Anti-tumor Activity of Toll-Like Receptor 7 Agonists

Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a bridging role in innate immunity and adaptive immunity. The activated TLRs not only induce inflammatory responses, but also elicit the development of antigen specific immunity. TLR7, a member of TLR family, is an int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Huju, Li, Chunman, Zhao, Flora Sha, Zhang, Li, Ng, Tzi Bun, Jin, Guangyi, Sha, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450331/ https://www.ncbi.nlm.nih.gov/pubmed/28620298 http://dx.doi.org/10.3389/fphar.2017.00304

Ejemplares similares

Trichosanthin increases Granzyme B penetration into tumor cells by upregulation of CI-MPR on the cell surface
por: Li, Chunman, et al.
Publicado: (2017)

A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
por: Chi, Huju, et al.
Publicado: (2022)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022)

Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice
por: Goldblatt, David L., et al.
Publicado: (2022)

Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy
por: Tang, Li, et al.
Publicado: (2019)

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
por: Cen, Xiaohong, et al.
Publicado: (2018)

Toll-Like Receptor 4 Signaling and Drug Addiction
por: Wu, Ruyan, et al.
Publicado: (2020)

Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
por: Sha, Ou, et al.
Publicado: (2013)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects
por: Liu, Yu, et al.
Publicado: (2020)

Breast Cancer Vaccine Containing a Novel Toll-like Receptor 7 Agonist and an Aluminum Adjuvant Exerts Antitumor Effects
por: Zhang, Shuquan, et al.
Publicado: (2022)

Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration
por: Chung, Lucia Yi-Ru, et al.
Publicado: (2022)

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
por: Hotz, Christian, et al.
Publicado: (2012)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

The Toll‐like receptor 7 agonist imiquimod increases ethanol self‐administration and induces expression of Toll‐like receptor related genes
por: Lovelock, Dennis F., et al.
Publicado: (2022)

Anti-fibrotic Potential of AT(2) Receptor Agonists
por: Wang, Yan, et al.
Publicado: (2017)

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
por: Celhar, Teja, et al.
Publicado: (2014)

Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway
por: Tong, Guoxiang, et al.
Publicado: (2022)

Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
por: Evans, Jay T., et al.
Publicado: (2019)

Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands
por: Alfaro, Victoria Y., et al.
Publicado: (2014)

Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
por: Caplan, Ian F., et al.
Publicado: (2018)

Toll-Like Receptor 4 in Paraventricular Nucleus Mediates Visceral Hypersensitivity Induced by Maternal Separation
por: Tang, Hui-Li, et al.
Publicado: (2017)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Mechanisms Underlying the Anti-Inflammatory Effects of Clinacanthus nutans Lindau Extracts: Inhibition of Cytokine Production and Toll-Like Receptor-4 Activation
por: Mai, Chun W., et al.
Publicado: (2016)

Bibliometric analysis of toll-like receptor agonists associated with cancer therapy
por: Li, Wei, et al.
Publicado: (2022)

Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma
por: Zhu, Jiang, et al.
Publicado: (2015)

Identification of a Small Molecular Insulin Receptor Agonist With Potent Antidiabetes Activity
por: Qiang, Guifen, et al.
Publicado: (2014)

Combining vasculature disrupting agent and toll-like receptor 7/8 agonist for cancer therapy
por: Seth, Anushree, et al.
Publicado: (2016)

Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
por: Angelopoulou, Athina, et al.
Publicado: (2020)

Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
por: Patinote, Cindy, et al.
Publicado: (2020)

Disease-Modifying Anti-rheumatic Drug Prescription Baihu-Guizhi Decoction Attenuates Rheumatoid Arthritis via Suppressing Toll-Like Receptor 4-mediated NLRP3 Inflammasome Activation
por: Li, Weijie, et al.
Publicado: (2021)

A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma
por: Lin, Guimiao, et al.
Publicado: (2015)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist
por: Hu, Zhiqiang, et al.
Publicado: (2013)

Anthrolysin O and Other Gram-positive Cytolysins Are Toll-like Receptor 4 Agonists
por: Park, Jin Mo, et al.
Publicado: (2004)

Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Cocaine-Mediated Behavior by Inhibiting Toll-Like Receptor 4 Signaling in Mice
por: Zhu, Changliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbh5lvhgdat25et3qac1u6ppa6